CCRRF yields 100000.00% · PFE yields 6.13%● Live data
📍 CCRRF pulled ahead of the other in Year 1
Combined, CCRRF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CCRRF + PFE for your $10,000?
Green River Gold Corp. engages in the acquisition, exploration, and development of mineral properties in Canada. It operates in two divisions, Retail and Mining. The company primarily explores for alluvial gold properties. Its principal project is the 100% owned Fontaine Gold Project that covers approximately 8,920 hectares located in British Columbia. The company also holds 100% interests in the Little Swift Gold and Sovereign Gold projects; the Kymar Silver project located in British Columbia; and the Quesnel Nickel/Cobalt Project consists of 8 contiguous mineral claims comprising 2,219.34 hectares located in British Columbia. In addition, it owns and operates retail stores that sells mining equipment. The company was formerly known as Greywacke Exploration Limited and changed its name to Green River Gold Corp. in August 2017. Green River Gold Corp. was incorporated in 2006 and is headquartered in Edmonton, Canada.
Full CCRRF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.